These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 1926062)
1. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062 [TBL] [Abstract][Full Text] [Related]
2. "In vitro" and "ex vivo" effects of picotamide, a combined thromboxane A2-synthase inhibitor and -receptor antagonist, on human platelets. Berrettini M; De Cunto M; Parise P; Grasselli S; Nenci GG Eur J Clin Pharmacol; 1990; 39(5):495-500. PubMed ID: 1963845 [TBL] [Abstract][Full Text] [Related]
3. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets. Pulcinelli FM; Pignatelli P; Riondino S; Parisi S; Castiglioni C; Gazzaniga PP Thromb Res; 1994 Jun; 74(5):453-61. PubMed ID: 8085246 [TBL] [Abstract][Full Text] [Related]
4. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets. Gresele P; Deckmyn H; Arnout J; Nenci GG; Vermylen J Thromb Haemost; 1989 Jun; 61(3):479-84. PubMed ID: 2552606 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM; Wu TS; Teng CM Br J Pharmacol; 1994 Mar; 111(3):906-12. PubMed ID: 8019768 [TBL] [Abstract][Full Text] [Related]
8. Inhibition by picotamide of thromboxane production in vitro and ex vivo. Violi F; Ghiselli A; Iuliano L; Praticò D; Alessandri C; Balsano F Eur J Clin Pharmacol; 1988; 33(6):599-602. PubMed ID: 3366163 [TBL] [Abstract][Full Text] [Related]
9. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase. Jeng JH; Chen SY; Liao CH; Tung YY; Lin BR; Hahn LJ; Chang MC Free Radic Biol Med; 2002 May; 32(9):860-71. PubMed ID: 11978487 [TBL] [Abstract][Full Text] [Related]
10. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets. Patscheke H; Stegmeier K Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261 [TBL] [Abstract][Full Text] [Related]
11. Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. Anfossi G; Parisi S; Russo I; Mularoni EM; Massucco P; Cavalot F; Mattiello L; Trovati M Thromb Res; 1995 Mar; 77(5):399-410. PubMed ID: 7778055 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of the persisting TxA2 receptor antagonism by picotamide. Pulcinelli FM; Pignatelli P; Pesciotti M; Sebastiani S; Parisi S; Gazzaniga PP Thromb Res; 1997 Feb; 85(3):207-15. PubMed ID: 9058495 [TBL] [Abstract][Full Text] [Related]
13. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related]
14. [In vitro study of the mechanism of the platelet anti-aggregant action of picotamide (G 137)]. Berrettini M; De Cunto M; Romanelli A; Volpato I; Orzalesi G; Nenci GG Boll Soc Ital Biol Sper; 1983 Mar; 59(3):309-15. PubMed ID: 9704127 [No Abstract] [Full Text] [Related]
15. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
16. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses. Gross PL; Rand ML; Barrow DV; Packham MA Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the effects of anti-thromboxane agents in platelet-vessel wall interaction. Buccellati C; Ciceri P; Ballerio R; Casagrande C; Folco G; Nicosia S Eur J Pharmacol; 2002 May; 443(1-3):133-41. PubMed ID: 12044803 [TBL] [Abstract][Full Text] [Related]
18. Interrelation of platelet aggregation, release reaction and thromboxane A2 production. Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682 [TBL] [Abstract][Full Text] [Related]
19. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production. Gentry PA; Niemuller C; Ross ML; Liptrap RM Comp Biochem Physiol A Comp Physiol; 1989; 94(1):47-51. PubMed ID: 2571453 [TBL] [Abstract][Full Text] [Related]
20. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism. Vezza R; Spina D; Tallarida RJ; Nathan M; Page CP; Gresele P Thromb Haemost; 1997 Nov; 78(5):1385-91. PubMed ID: 9408024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]